This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Arthroplasty, Hip
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to evaluate the effects of transfusion of red blood cells in treating postoperative dizziness in patients with moderate postoperative anemia after total hip arthroplasty.

Provided treatments

  • Other: Red blood cell transfusion
  • Drug: Voluven

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01452581. The sponsor of the trial is Rigshospitalet, Denmark and it is looking for 5 volunteers for the current phase.
Official trial title:
Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty